றிக்கேன் ஜநெஸிஸ் இணை லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from றிக்கேன் ஜநெஸிஸ் இணை லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In றிக்கேன் ஜநெஸிஸ் இணை லிமிடெட் Today - Breaking & Trending Today

AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as


AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic for 9 Targeted Therapies for Use in Patients with Advanced Non-Small Cell Lung Cancer
PREMIA Holdings (HK) Ltd.
Hong Kong, HONG KONG
TOKYO and XIAMEN, China, June 30, 2021 (GLOBE NEWSWIRE) Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd. (“PREMIA”) today announced that the AmoyDx
® Pan Lung Cancer PCR Panel (the “AmoyDx PLC Panel”), an in vitro diagnostic reagent developed as a companion diagnostic for multiple anti-cancer agents, was approved by Ministry of Health, Labour and Welfare (MHLW) for production and marketing in Japan on June 25, 2021. ....

South Korea , Pan Lung , Paul Huang , Kenji Iwakabe , Wenn Sun , Panel The Amoydx , Precision Medicine Asia Co Ltd , Riken Genesis Co Ltd , Ministry Of Health , Amoy Diagnostics Co Ltd , Marketing Department , Pan Lung Cancer , Riken Genesis , Li Mou Zheng , Marketing Authorization , Precision Medicine Asia , தெற்கு கொரியா , பால் ஹுவாங் , றிக்கேன் ஜநெஸிஸ் இணை லிமிடெட் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , அமோய் பரிசோதனை இணை லிமிடெட் , சந்தைப்படுத்தல் துறை , றிக்கேன் ஜநெஸிஸ் , சந்தைப்படுத்தல் அங்கீகாரம் , ப்ரிஸிஶந் மருந்து ஆசியா ,

Next Generation Sequencing (NGS) Markets in Japan and the Impact of the COVID-19 Pandemic in 2020 - ResearchAndMarkets.com - Press Release


Next Generation Sequencing (NGS) Markets in Japan and the Impact of the COVID-19 Pandemic in 2020 - ResearchAndMarkets.com
ResearchAndMarkets.com s offering.
This report analyses the market trends influencing various NGS market segments in Japan. It also analyses the global market trends, which have a significant impact in Japan s NGS market. It covers a detailed analysis of the impact of COVID-19 in each market segment.
This is an updated version of the study conducted in 2019. The estimations and forecasts in the original version have been revisited for accommodating the impact of COVID-19, which has affected all the sub-segments across the NGS markets in Japan. The base year of the study is maintained as 2019 since the pandemic situation is still evolving and impact is uncertain to a large extent. The original estimates for each market segment have been revised for 2020 and beyond in this updated version. Response to COVID-19 by each leading market player in Japan h ....

Pacific Biosciences , Laura Wood , Health Insurance Landscape , Sysmex Corporation , Perkinelmer Inc , Genesis Healthcare Co , Agilent Technologies , Takara Bio Inc , Genomics Inc , Research Applications , Genewiz Japan Genewith Co Ltd , Roche Ltd , Office Hours Call , Riken Genesis Co Ltd , Foundation Medicine Inc , Company Profiles , E St Office Hours Call , Macrogen Inc , Genequest Co Ltd , Business Wire , Next Generation Sequencing , Topics Covered , Insurance Landscape , Genome Sequencing , Exome Sequencing , Growth Trends ,

Kobe University and Sysmex conducted clinical evaluation of the ELISPOT method: A new test for COVID


Credit: Sysmex/Kobe University
Kobe University (Location: Kobe, Japan; President: Hiroshi Takeda) and Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) have been engaged in joint research on the ELISPOT method, a new blood test for identifying the novel coronavirus disease (COVID-19). This method makes it possible to detect the immune response of T cells to the novel coronavirus (SARS-CoV-2). Here we provide an overview of the method and the results of the clinical evaluation. This information will also be made available through conference presentations and by paper submission.
Although SARS-CoV-2 is highly infectious and may rapidly develop into a severe condition, many carriers of the virus are asymptomatic. To address this situation, research has been carried out to develop ways in which vaccine efficacy and safety can be assessed, in addition to the tests conducted in the period shortly after SARS-CoV-2 infection through to the treatment / recover ....

United States , United Kingdom , Oxford Immunotec , Hiroshi Matsuoka , Hisashi Ietsugu , Hiroshi Takeda , Kobe University Hospital Bioresource Center Location , Kobe University Location , Riken Genesis Co Ltd , Drug Administration , Kobe University With , Sysmex Corporation , Kobe University , Oxford Immunotec Global , Oxford Immunotec Ltd , Japan Agency For Medical Research , Oxford University , Kobe University Hospital Bioresource Center , Vaccines Taskforce , Japan Agency , Medical Research , Kobe City , Cell Biology , Medicine Health , Clinical Trials , Immunology Allergies Asthma ,

Next Generation Sequencing (NGS) Markets in Japan - Market Size and Growth Trends by Products and Services - Press Release


Next Generation Sequencing (NGS) Markets in Japan - Market Size and Growth Trends by Products and Services
ResearchAndMarkets.com s offering.
This report analyses the market trends influencing various NGS market segments in Japan. It also analyses the global market trends, which have a significant impact in Japan s NGS market. It covers a detailed analysis of the impact of COVID-19 in each market segment.
This is an updated version of the study conducted in 2019. The estimations and forecasts in the original version have been revisited for accommodating the impact of COVID-19, which has affected all the sub-segments across the NGS markets in Japan. The base year of the study is maintained as 2019 since the pandemic situation is still evolving and impact is uncertain to a large extent. The original estimates for each market segment have been revised for 2020 and beyond in this updated version. Response to COVID-19 by each leading market player in Japan has also been e ....

Pacific Biosciences , Laura Wood , Health Insurance Landscape , Sysmex Corporation , Perkinelmer Inc , Genesis Healthcare Co , Agilent Technologies , Takara Bio Inc , Genomics Inc , Research Applications , Genewiz Japan Genewith Co Ltd , Custom Research , Roche Ltd , Office Hours Call , Riken Genesis Co Ltd , Foundation Medicine Inc , Company Profiles , E St Office Hours Call , Macrogen Inc , Genequest Co Ltd , Next Generation Sequencing , Topics Covered , Insurance Landscape , Genome Sequencing , Exome Sequencing , Growth Trends ,